U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07643922) titled 'Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage' on June 01.
Brief Summary: Cerebral vasospasm is a common and serious complication after aneurysmal subarachnoid hemorrhage and is an important cause of delayed cerebral ischemia and poor neurological outcomes. Although standardized medical management is widely used, effective treatment options for cerebral vasospasm remain limited.
Endovascular treatment, including intra-arterial drug infusion and mechanical angioplasty, may relieve vasospasm and improve cerebral perfusion after aneurysmal subarachnoid hemorrhage. However, most available evidence...